spacer
home > ict > spring 2018 > clinical navigation
PUBLICATIONS
International Clinical Trials

Clinical Navigation

Over the last decade within pharmacovigilance, significant developments and improvements to regulations have been made. With the revision of regulations occurring within multiple countries and regions, the pressure on sponsors/marketing authorisation holders (MAHs) to be knowledgeable of and abide by these is an ongoing challenge. Outsourcing different tasks and responsibilities is one available option. CROs are often able to provide sponsors (and/or MAHs within said sponsors) with greater global reach through coverage in multiple countries and take a proactive approach to remain knowledgeable on the current pharmacovigilance regulations to properly advise sponsors. Furthermore, CROs not only have the ability to advise sponsors, but also the skills, processes, systems, and resources to be able to adhere to this continually changing and costly environment, while still providing a high-quality service and maintaining compliance.

A shift in dynamic has been marked from the typical clientcontractor relationship, where sponsors may now see CROs as their collaborative partner and, essentially, an extension of their company. CROs must recognise that each sponsor may have different needs and expectations and therefore appreciate the need to be flexible, while still remaining compliant with all regulations as the ultimate responsibility for pharmacovigilance activities remain with the sponsor. However, the willingness of sponsors to listen to advice from CROs and make informed decisions on best practice means that they remain compliant. This article will explore several instances where CRO support may be required by sponsors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Nick Barker is a Director of Clinical Safety for Medpace, working closely with sponsors to support adherence to regulations. He has experience in pharmacovigilance across all clinical trial phases for various indications, as well as post-marketing. Nick’s key interests lie in the translation of regulations into processes, through the development of procedures and process improvements.

Katharine Colbert RN, BSN, MSBM, MPH, is a Senior Safety Manager at Medpace with a strong clinical background in paediatric oncology/stem cell transplant. With 17 years of industry experience, she has extensive global knowledge in various therapeutic areas within both clinical safety and post-marketing pharmacovigilance.
spacer
Nick Barker
spacer
spacer
spacer
Katharine Colbert
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

TrialScope Taps Industry Veteran as CTO

JERSEY CITY, NJ, July 29, 2019 – TrialScope, the global leader in clinical trial transparency and compliance solutions, announces the appointment of Ruben Echandy as Chief Technology Officer.
More info >>

White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement